SYNGO DUAL ENERGY WITH EXTENDED FUNATIONALLY
K083524 · Siemens Medical Solutions USA, Inc. · JAK · Apr 1, 2009 · Radiology
Device Facts
| Record ID | K083524 |
| Device Name | SYNGO DUAL ENERGY WITH EXTENDED FUNATIONALLY |
| Applicant | Siemens Medical Solutions USA, Inc. |
| Product Code | JAK · Radiology |
| Decision Date | Apr 1, 2009 |
| Decision | SESE |
| Submission Type | Special |
| Regulation | 21 CFR 892.1750 |
| Device Class | Class 2 |
Intended Use
Syngo Dual Energy is designed to operate with Siemens Dual Source CT scanners. CT images taken at the same time, using two different kV levels, of the same anatomical region of a patient are used. Depending on the region of interest, contrast agents may be used. The differences in the energy dependence of the attenuation coefficient of the different materials provide information about the chemical composition of body materials. The images are combined to visualize and analyze information about anatomical and pathological structures.
Device Story
Software package for Siemens Dual Source CT scanners; processes simultaneous CT images acquired at two different kV levels. Exploits energy-dependent attenuation coefficient differences to characterize chemical composition of body materials. Enables visualization/analysis of anatomical and pathological structures. Used by radiologists/clinicians in clinical settings to assist in diagnostic tasks including lung nodule assessment, bone removal, and tissue characterization (e.g., gout, kidney stones). Output provides enhanced diagnostic information to support clinical decision-making.
Clinical Evidence
No clinical data provided. Safety and effectiveness supported by software verification, validation testing, and hazard analysis.
Technological Characteristics
Software-based image processing package for Siemens Dual Source CT systems. Operates on dual-energy attenuation data. Implements various clinical application modules for tissue/pathology analysis. Adheres to established industry standards for software development and risk management.
Indications for Use
Indicated for visualization and analysis of anatomical and pathological structures using dual-source CT imaging. Applications include lung nodules, lung ventilation (xenon), monoenergetic imaging, brain hemorrhage, gout evaluation, lung vessels, heart PBV, bone removal, cartilage/tendon/ligament assessment, lung perfusion, liver analysis, hard plaque vessel assessment, and kidney stones.
Regulatory Classification
Identification
A computed tomography x-ray system is a diagnostic x-ray system intended to produce cross-sectional images of the body by computer reconstruction of x-ray transmission data from the same axial plane taken at different angles. This generic type of device may include signal analysis and display equipment, patient and equipment supports, component parts, and accessories.
Predicate Devices
- syngo Dual Energy (K073003)
- syngo Oncology (K071310)
- SOMATOM DR I (K837107)
Related Devices
- K073003 — SYNGO DUAL ENERGY WITH EXTENDED FUNCTIONALLY · Siemens Medi Cal Solutions, Inc. · Feb 7, 2008
- K062351 — SYNGO DUAL ENERGY · Siemens Medical Solutions USA, Inc. · Oct 5, 2006
- K150757 — syngo.CT Dual Energy · Siemens Medical Solutions USA, Inc. · Aug 11, 2015
- K232155 — syngo.CT Dual Energy · Siemens Medical Solutions USA, Inc. · Nov 30, 2023
- K150745 — syngo.CT Single Source Dual Energy · Siemens Medical Solutions USA, Inc. · Aug 11, 2015
Submission Summary (Full Text)
{0}------------------------------------------------
1083524
Attachment 8
Summary
# APR - 1 2009
## 510(k) - Summary
SIEMENS
This summary of 510(k) safety and effectiveness information is being submitted in accordance with the requirements of SMDA 1990 and 21 CFR \$807.92.
#### I. GENERAL INFORMATION
- Device Name and Classification 1.
| Product Name: | syngo® Dual Energy with extended functionality |
|-----------------------|------------------------------------------------|
| Classification Name: | Accessory to Computed Tomography System |
| Classification Panel: | Radiology |
| CFR Section: | 21 CFR §892.1750 |
| Device Class: | Class II |
| Product Code: | 90 JAK |
## 2. Importer/Distributor Establishment: Registration Number: 2240869
Siemens Medical Solutions, Inc. 51 Valley Stream Pkwy Malvern, PA 19355
#### 3. Manufacturing Facility:
Siemens AG Medical Solutions Henkestrasse 127
D-91052 Erlangen, Germany
- Contact Person: 4.
Mrs. Corrine McLeod
## Date of Preparation of Summary: September 10th 2007 ട.
510(k) submission for SIEMENS ' syngo Dual Energy
{1}------------------------------------------------
## Summary
# SIEMENS
## SAFETY AND EFFECTIVENESS INFORMATION SUPPORTING THE SUBSTANTIAL II. EQUIVALENCE DETERMINATION
#### General Safety and Effectiveness Concerns: 6.
The device Iabeling contains instructions for use and any necessary cautions and warnings, to provide for safe and effective use of the device.
Risk management is ensured via a hazard analysis, which is used to identify potential hazards. These potential hazards are controlled via software development, verification and validation testing. To minimize electrical, mechanical, and radiation hazards, Siemens adheres to recognized and established industry practice and standards.
#### Substantial Equivalence: 7.
The syngo® Dual Energy software package that is addressed in this premarket notification, is substantially equivalent to the following commercially available Siemens Medical Systems devices :
| Manufacturer | Product | 510(k) | Clearance date |
|--------------|-------------------|---------|----------------|
| 1. Siemens | syngo Dual Energy | K073003 | 02/07/2008 |
| 2. Siemens | syngo Oncology | K071310 | 06/08/2007 |
| 3. Siemens | SOMATOM DR I | K837107 | 03/09/1983 |
### Device Description and Intended Use: 8.
## Device Name: syngo® Dual Energy with extended functionality
Syngo Dual Energy is designed to operate with Siemens Dual Source CT scanners. CT images taken at the same time, using two different kV levels, of the same anatomical region or a pattern a le penting our trist egion of minterest contrast agentis may be useum int differences in the energy dependence of the attenuation coefficient of the different materials provide information about the chemical composition of body materials. The Images are combined to visualize and analyze information about anatomical and pathological structures.
The functionality of the syngo® Dual Energy applications are as follows:
- Lung Nodules .
- Xenon (Lung Ventilation) .
- · Monoenergetic · · · ·
- Brain Haemorrhage ●
- Gout Evaluation .
- . Lung Vessels
- Heart PBV .
- Dual Energv Bone Removal
- Cartilage, Tendon, Ligament
- Lung Perfusion .
- Liver ●
- Hard Plaques in Vessels
- Kidney Stones
{2}------------------------------------------------
Image /page/2/Picture/0 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo is a circular seal with the words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is an abstract image of an eagle with three lines representing its wings and body. The eagle is facing to the right.
## DEPARTMENT OF HEALTH & HUMAN SERVICES
Public Health Service
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
APR - 1 2009
Ms. Corrine McLeod Regulatory Affairs Specialist Siemens Medical Solutions USA, Inc. Corporate Headquarters 51 Valley Stream Parkway MALVERN PA 19355
Re: K083524
Trade/Device Name: syngo® Dual Energy with extended functionality Regulation Number: 21 CFR 892.1750 Regulation Name: Computed tomography x-ray system
Regulatory Class: II
Product Code: JAK
Dated: March 4, 2009
Received: March 16, 2009
Dear Ms. McLeod:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
{3}------------------------------------------------
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801; good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding os substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at one of the following numbers, based on the regulation number at the top of this letter.
| 21 CFR 876.xxx | (Gastroenterology/Renal/Urology) | (240) 276-0115 |
|----------------|----------------------------------|----------------|
| 21 CFR 884.xxx | (Obstetrics/Gynecology) | (240) 276-0115 |
| 21 CFR 892.xxx | (Radiology) | (240) 276-0120 |
| Other | | (240) 276-0100 |
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding postmarket surveillance, please contact CDRH's Office of Surveillance and Biometrics' (OSB's) Division of Postmarket Surveillance at 240-276-3474. For questions regarding the reporting of device adverse events (Medical Device Reporting -(MDR)) - please contact the Division of Surveillance -Systems at -240-276-3464. - You may obtain other general information on your responsibilities under the Act from the Division of Small Manufactures, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrh/industry.suppo/index.html.
Sincerely yours,
Janine M. Morris
anine M. Morris Acting Director, Division of Reproductive. Abdominal, and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health
Page 2
{4}------------------------------------------------
# Indication for use
510(k) Number: K083524
Device Name: syngo Dual Energy with extended functionality
Syngo Dual Energy is designed to operate with Siemens Dual Source CT scanners. CT images taken at the same time, using two different kV levels, of the same anatomical region of a patient are used. Depending on the region of interest, contrast agents may be used. The differences in the energy dependence of the attenuation coefficient of the different materials provide information about the chemical composition of body materials. The images are combined to visualize and analyze information about anatomical and pathological structures.
The functionality of the syngo® Dual Energy applications are as follows:
- Lung Nodules �
Xenon (Lung Ventilation)
- Monoenergetic .
- Brain Haemorrhage .
- Gout Evaluation
- Lung Vessels
- Heart PBV
- Dual Energy Bone Removal
- Cartilage, Tendon, Ligament .
- Lung Perfusion .
- Liver .
- Hard Plaques in Vessels
- Kidney Stones
Prescription Use > (Part 21 CFR 801 Subpart D)
AND/OR
Over-The-Counter Use(Part 21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)
| Concurrence of the CDRH, Office of Device Evaluation (ODE) | Page ___ of ___ |
|--------------------------------------------------------------|-----------------|
| (Division Sign-Off) | |
| Division of Reproductive, Abdominal and Radiological Devices | |
| 510(k) Number | K083524 |